The modeling of multicancer early detection (MCED) tests′residual risk and the challenges of MCED evaluation and implementation

被引：3

作者：

Kessler, Larry ^{[1
]}

Le Beau, Michelle M. ^{[2
,3
]}

Smith, Robert A. ^{[4
]}

Walter, Fiona M. ^{[5
,6
]}

Wender, Richard ^{[7
]}

机构：

[1] Univ Washington, Sch Publ Hlth, Dept Hlth Syst & Populat Hlth, 3980 15th Ave NE,UW Box 351621, Seattle, WA 98195 USA

[2] Univ Chicago, Med Hematol Oncol, Chicago, IL USA

[3] Canc Prevent & Res Inst Texas, Austin, TX USA

[4] Amer Canc Soc, Early Canc Detect Sci, Atlanta, GA USA

[5] Wolfson Inst Populat Hlth, London, England

[6] Queen Mary Univ London, Primary Care Canc Res, London, England

[7] Univ Penn, Perelman Sch Med, Family Med & Community Hlth, Philadelphia, PA USA

来源：

CANCER | 2023年 / 129卷 / 13期

关键词：

DIAGNOSIS; CANCER;

D O I：

10.1002/cncr.34745

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multicancer early detection (MCED) tests represent a potentially game-changing early cancer detection technology. Modeling efforts, such as those of Hudnut et al. in this issue of Cancer, as well as systematic clinical studies and data collection, along with public health and primary care efforts, need to be undertaken to determine whether MCED tests become an opportunity to decrease the heavy burden of cancer for all.

引用

页码：1966 / 1968

页数：3

共 50 条

[1] COST-EFFECTIVENESS OF MULTICANCER EARLY DETECTION (MCED) WITH PREFERENTIAL DETECTION OF CLINICALLY AGGRESSIVE CANCERS
Kansal, A.
Tafazzoli, A.
Shaul, A.
Ye, W.
Chavan, A.
Zou, D.
Fendrick, A. M.
VALUE IN HEALTH, 2023, 26 (12) : S149 - S149
[2] DRIVERS OF VALUE-BASED PRICE (VBP) FOR A MULTICANCER EARLY DETECTION (MCED) TEST
Tafazzoli, A.
Ramsey, S. D.
Shaul, A.
Chavan, A.
Ye, W.
Chung, K. C.
Kansal, A. R.
Fendrick, A. M.
VALUE IN HEALTH, 2022, 25 (01) : S68 - S68
[3] Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests
Heather Gelhorn
Melissa M. Ross
Anuraag R. Kansal
Eric T. Fung
Michael V. Seiden
Nicolas Krucien
Karen C. Chung
The Patient - Patient-Centered Outcomes Research, 2023, 16 : 43 - 56
[4] Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests
Gelhorn, Heather
Ross, Melissa M.
Kansal, Anuraag R.
Fung, Eric T.
Seiden, Michael V.
Krucien, Nicolas
Chung, Karen C.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2023, 16 (01): : 43 - 56
[5] Considerations in the implementation of multicancer early detection tests
Nadauld, Lincoln
Goldman, Dana P.
FUTURE ONCOLOGY, 2022, 18 (28) : 3119 - 3124
[6] A case of stage IIA anal squamous cell carcinoma (SCC) diagnosed using a multicancer early detection (MCED) test
Myers, David A.
Wood, Brenda
CANCER RESEARCH, 2023, 83 (07)
[7] PUBLIC PERSPECTIVES ON EMERGING MULTI-CANCER EARLY DETECTION (MCED) TESTS: A QUALITATIVE STUDY
Crossnohere, N.
Campoamor, N.
Negash, R.
Wood, M.
Studts, J.
Jonas, D.
Elsaid, M.
Donneyong, M.
Bridges, J. F. P.
VALUE IN HEALTH, 2024, 27 (06) : S284 - S284
[8] OPTIMIZING MULTICANCER EARLY DETECTION (MCED) TESTING BASED ON PATIENT STRATIFICATION: A COMPREHENSIVE ANALYSIS OF ECONOMIC AND CLINICAL IMPACT FROM A US PAYER PERSPECTIVE
Long, B.
Alhegelan, M.
Fried, M.
VALUE IN HEALTH, 2024, 27 (06) : S136 - S136
[9] Perceptions of multi-cancer early detection (MCED) screening tests among underrepresented populations
Cong, Ze
Ross, Melissa
Mulnick, Sarah
Samuelson, Ashley
Chung, Karen
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[10] A multi-cancer early detection (MCED) test: clinical update for GPs
Save, Tanvi
Neal, Richard D.
Round, Thomas
BRITISH JOURNAL OF GENERAL PRACTICE, 2024, 74 (745): : 380 - 382

← 1 2 3 4 5 →